V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320007379 | 320003888 | 1.85 | 85.6 | Palliative (P) | 2014-10-18 | 2014-10-18 | Trial Unspecified | 02 | N | 320020709 | TRIAL |
| 320007380 | 320003896 | 1.54 | 54.8 | Palliative (P) | 2016-04-04 | 2016-04-05 | Temozolomide 150mg/m2 | 02 | N | 320020795 | DOCETAXEL + GEMCITABINE |
| 320007381 | 320005781 | 1.65 | null | Palliative (P) | 2015-10-06 | 2015-10-15 | TEMOZOLOMIDE | N | N | 320021011 | DOCETAXEL |
| 320007382 | 320003920 | null | 63 | Palliative (P) | 2015-02-13 | 2015-02-20 | CISPLATIN + GEMCITABINE | 02 | null | 320022758 | FLUOROURACIL + MITOMYCIN + RT |
| 320007383 | 320003923 | 1.8 | 70.4 | Palliative (P) | 2017-09-13 | 2018-01-02 | CARBOPLATIN + RT | N | N | 320022776 | NIVOLUMAB |
| 320007384 | 320006690 | null | 79.9 | Palliative (P) | 2020-01-07 | 2020-01-07 | TCF | 2 | N | 320022811 | CARBOPLATIN + RT |
| 320007385 | 320003930 | 1.65 | null | Palliative (P) | 2018-09-10 | 2018-10-01 | Niraparib | N | N | 320022821 | Y-90 |
| 320007386 | 320003970 | null | 87.2 | Palliative (P) | 2018-09-08 | 2018-09-08 | Capecitabine | 2 | N | 320023192 | PEMBROLIZUMAB |
| 320007387 | 320005825 | 1.86 | 94 | Palliative (P) | 2016-07-20 | 2017-01-20 | PEMBROLIZUMAB | N | N | 320023276 | CARBOPLATIN + ETOPOSIDE |
| 320007388 | 320003991 | 1.56 | 0 | Palliative (P) | 2016-09-03 | 2016-12-24 | Doxorubicin 75mg/m2 | N | N | 320023393 | CYCLOPHOSPHAMIDE |
| 320007389 | 320007482 | 1.77 | 85 | Palliative (P) | 2015-10-24 | 2015-12-25 | CISPLATIN + ETOPOSIDE | N | N | 320023465 | PEMBROLIZUMAB |
| 320007390 | 320004042 | 1.81 | 60 | Palliative (P) | 2018-07-12 | 2018-10-12 | CETUXIMAB + CISPLATIN + FU | 02 | N | 320023838 | CARBO + FLUOROURACIL |
| 320007391 | 320004055 | 1.76 | 79 | Palliative (P) | 2018-07-21 | 2018-08-01 | EW EuroEwing 99 : VActI | N | N | 320023924 | CARBOPLATIN + RT |
| 320007392 | 320004059 | 1.76 | 59 | Palliative (P) | 2018-05-10 | 2018-06-14 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 320023958 | IVA |
| 320007393 | 320004089 | 1.68 | 67.6 | Palliative (P) | null | 2017-07-21 | PEMBROLIZUMAB | N | N | 320025218 | CARBOPLATIN + ETOPOSIDE |
| 320007394 | 320004138 | 1.61 | null | Palliative (P) | 2015-10-05 | 2019-05-02 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 320008744 | INOVATYON TRIAL |
| 320007395 | 320004157 | 1.73 | 84.6 | Adjuvant (A) | 2019-05-12 | 2019-05-12 | TOPOTECAN | 02 | N | 320009487 | Y-90 |
| 320007396 | 320004169 | 1.86 | 64 | Adjuvant (A) | 2016-09-28 | 2016-09-29 | Ifosfamide | N | N | 320011028 | AFLIBERCEPT + FU + IRINOTECAN |
| 320007397 | 320004184 | 1.72 | 54.6 | Palliative (P) | 2019-06-11 | 2019-07-28 | PCV | N | N | 320012197 | NAB-PACLITAXEL |
| 320007398 | 320004198 | 1.5 | 67 | Palliative (P) | null | 2019-05-16 | EMA | null | null | 320014151 | ICON8B TRIAL |
| 320007399 | 320004215 | null | 91 | Palliative (P) | 2016-10-03 | 2016-10-04 | Bevacizumab+Carbo+Gemcitabine | N | N | 320018048 | ETOPOSIDE |
| 320007400 | 320005940 | 1.73 | 65.2 | Palliative (P) | 2016-06-03 | 2016-09-03 | Cyclophosphamide oral | N | N | 320019034 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320007401 | 320006758 | 1.7 | 45.2 | Adjuvant (A) | 2017-12-13 | 2017-12-29 | Sunitinib | N | N | 320021324 | DOXORUBICIN |
| 320007402 | 320004275 | 1.7 | 99.2 | Curative (C) | 2016-12-08 | 2017-01-27 | CYCLOPHOSPHAMIDE | 02 | N | 320021893 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320007403 | 320004306 | 1.81 | 86.5 | Palliative (P) | 2018-11-04 | 2019-01-03 | Temozolomide 200mg/m2 | 02 | N | 320008581 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007404 | 320004309 | 1.65 | 70.4 | Palliative (P) | 2016-08-24 | 2017-08-24 | OCTREOTIDE | 2 | N | 320009033 | CETUXIMAB + CISPLATIN + FU |
| 320007405 | 320002686 | 1.58 | 73.2 | Palliative (P) | 2015-07-01 | 2015-07-09 | CARBOPLATIN + PACLITAXEL | 99 | N | 320001353 | CARBOPLATIN + PACLITAXEL |
| 320007406 | 320002700 | 1.76 | 46.9 | Palliative (P) | 2016-01-24 | 2016-02-16 | CARBOPLATIN + PACLITAXEL | 02 | N | 320002703 | CARBOPLATIN + PACLITAXEL |
| 320007407 | 320005217 | 1.58 | 66 | Palliative (P) | null | 2016-09-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 320003344 | CARBOPLATIN + PACLITAXEL |
| 320007408 | 320002779 | 1.58 | null | Palliative (P) | 2019-03-08 | 2019-03-13 | Carboplatin + Paclitaxel (3 weekly) | N | N | 320004067 | CARBOPLATIN + PACLITAXEL |
| 320007409 | 320002790 | 1.5 | 61.2 | Disease modification (D) | 2016-05-01 | 2016-06-18 | Bevacizumab 7.5mg/kg | N | N | 320004163 | BEVACIZUMAB |
| 320007410 | 320002797 | 1.87 | 75 | Disease modification (D) | 2018-11-13 | 2019-10-03 | Bevacizumab 7.5mg/kg | 02 | N | 320004218 | BEVACIZUMAB |
| 320007411 | 320002805 | 1.58 | 74 | Palliative (P) | 2019-07-29 | 2019-08-28 | Paclitaxel 7 day | N | N | 320004279 | PACLITAXEL |
| 320007412 | 320002821 | 1.61 | null | Palliative (P) | null | 2018-01-15 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 320004533 | PACLITAXEL |
| 320007413 | 320002842 | null | null | Palliative (P) | 2016-01-19 | 2016-07-13 | Bevacizumab 7.5mg/kg | 02 | N | 320004871 | BEVACIZUMAB |
| 320007414 | 320002872 | 1.78 | 70.4 | Palliative (P) | 2018-08-24 | 2018-08-26 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 320005386 | CARBOPLATIN + PACLITAXEL |
| 320007415 | 320005302 | 1.7 | 68.4 | Palliative (P) | 2018-04-12 | 2018-04-12 | Paclitaxel 7 day | N | N | 320006001 | PACLITAXEL |
| 320007416 | 320002923 | 1.64 | null | Palliative (P) | 2018-01-17 | 2018-03-28 | Carboplatin AUC 6 - 10 | N | N | 320006658 | CARBOPLATIN |
| 320007417 | 320003012 | 1.74 | 62.8 | Palliative (P) | 2017-10-20 | 2017-10-25 | Carboplatin AUC 6 - 10 | Y | N | 320009009 | CARBOPLATIN |
| 320007418 | 320003067 | 1.71 | 65.6 | Palliative (P) | 2016-04-22 | 2016-04-23 | CARBOPLATIN | N | N | 320010408 | CARBOPLATIN |
| 320007420 | 320003191 | 1.61 | 67.9 | Palliative (P) | 2018-05-10 | 2018-05-19 | Paclitaxel (2 or 3 weekly) | 2 | N | 320013818 | PACLITAXEL |
| 320007421 | 320003222 | 1.61 | null | null | 2018-08-25 | 2018-09-06 | Liposomal Doxorubicin 40mg/m2 | N | N | 320014108 | LIPOSOMAL DOXORUBICIN |
| 320007422 | 320003230 | 1.68 | 67.8 | Palliative (P) | 2018-10-04 | 2018-10-19 | GemCarbo Days 1+8 | 02 | N | 320014157 | GEMCARBO |
| 320007423 | 320006536 | 1.71 | 72.9 | Palliative (P) | 2016-02-21 | 2016-03-08 | Cisplatin | N | N | 320014364 | CISPLATIN |
| 320007424 | 320003366 | 1.74 | 52.4 | Palliative (P) | 2020-01-02 | 2020-01-02 | GEMCARBO | 02 | Y | 320014965 | GEMCARBO |
| 320007425 | 320003371 | 1.84 | null | Palliative (P) | 2018-09-13 | 2018-09-20 | Liposomal Doxorubicin 40mg/m2 | 02 | null | 320014992 | LIPOSOMAL DOXORUBICIN |
| 320007426 | 320003520 | 1.77 | 121.95 | Palliative (P) | 2018-08-27 | 2018-09-19 | Carboplatin + Liposomal Doxorubicin | Y | N | 320015848 | CARBOPLATIN + LIPOSOMAL DOX |
| 320007427 | 320003556 | 1.59 | 93.6 | Palliative (P) | 2019-02-17 | 2019-02-26 | null | N | N | 320016065 | NOT MATCHED |
| 320007428 | 320003608 | 1.72 | 66 | Palliative (P) | 2019-05-14 | 2019-05-14 | CNS LGG | 02 | N | 320016767 | NOT MATCHED |
| 320007429 | 320005730 | null | 68.5 | Palliative (P) | 2017-11-11 | 2017-12-05 | CARBOPLATIN + GEMCITABINE | 02 | N | 320019230 | GEMCARBO |